Alongside pharmaceutical and biopharmaceutical manufacturers, we help make life-enhancing drugs a reality.
From Concept to Market: Delivering Flexible Solutions for our Customers
We collaborate with our customers to develop flexible manufacturing solutions that support bringing molecules to market, improving process economics, and managing risks. Our approach and solutions acknowledge that each drug is unique and requires specific considerations for process development, scale-up, and on-going production.
Through our End-to-End solutions, we work with biopharma customers on clinical drug development, scaling processes and implementing local production facilities, globally. We have the ability to execute a full manufacturing process – including designing and implementing at the customer’s facility or at our own GMP site in Martillac, France. We are a leader in helping customers bring cutting-edge novel therapies to market with world-class process development and manufacturing capabilities for virus-based therapeutics.
Our customers need to get therapeutics to patients quickly and safely
Our extensive offering of products and services brings together the industry-leading filtration and systems portfolio of Millipore®, the standard-setting chemicals portfolio of SAFC®
and Merck KGaA, Darmstadt, Germany, and the trusted range of services from BioReliance®. Knowledge of customer needs allows us to bring to market innovative products and services that help reduce production costs, increase process reliability, and gain production efficiencies.
We understand that our customers need to get therapeutics to patients quickly and safely. To satisfy their needs while managing risk, we ensure that our products not only meet the highest quality and purity standards, but we also employ our EMPROVE® program, which offers extensive documentation to help ensure regulatory compliance. Our operational processes offer customers supply chain transparency, reliability, and predictability to help protect customers’ drugs throughout the manufacturing process.
Life Science Tools
Reaching the potential of CRISPR technology
CRISPR-based genomic scissors opens up new possibilities in medicine and biotechnology. Researchers put their trust in life science tools from our company. Learn more
Accelerating Global Access to Affordable Vaccines
Influenza, Malaria, Schistosomiasis, Typhoid, Cholera, Measles, adults, children and Merck KGaA, Darmstadt, Germany. What do they all have in common?
You have accessed emdgroup.com, but for users from your part of the world, we originally designed the following web presence merckgroup.com